Free fatty acid as a determinant of ischemic lesion volume in nonarterial-origin embolic stroke

[1]  J. Spence,et al.  Transcranial Doppler is Complementary to Echocardiography for Detection and Risk Stratification of Patent Foramen Ovale. , 2016, The Canadian journal of cardiology.

[2]  A. Sahebkar,et al.  Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials. , 2016, British journal of clinical pharmacology.

[3]  C. Chung,et al.  Brain microangiopathy and macroangiopathy share common risk factors and biomarkers. , 2016, Atherosclerosis.

[4]  H. Kamel,et al.  Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model , 2016, Stroke.

[5]  Jeong-Yoon Choi,et al.  Free fatty acid as an outcome predictor of atrial fibrillation–associated stroke , 2016, Annals of neurology.

[6]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  Jeong-Yoon Choi,et al.  High free fatty acid level is associated with recurrent stroke in cardioembolic stroke patients , 2014, Neurology.

[8]  S. Connolly,et al.  Embolic strokes of undetermined source: the case for a new clinical construct , 2014, The Lancet Neurology.

[9]  B. Ovbiagele,et al.  Evaluation of Cryptogenic Stroke With Advanced Diagnostic Techniques , 2014, Stroke.

[10]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[11]  D. Kent,et al.  An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke , 2013, Neurology.

[12]  L. Sechi,et al.  Oxidative stress is activated by free fatty acids in cultured human hepatocytes. , 2011, Metabolic syndrome and related disorders.

[13]  Irene Katzan,et al.  Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. , 2011, Stroke.

[14]  J. Spence.  Secondary stroke prevention , 2010, Nature Reviews Neurology.

[15]  R. Sacco,et al.  Aortic Arch Plaques and Risk of Recurrent Stroke and Death , 2009, Circulation.

[16]  David S. Liebeskind,et al.  Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke , 2009, Journal of Neurology.

[17]  J. Spence,et al.  Cryptogenic stroke and patent foramen ovale: Clinical clues to paradoxical embolism , 2008, Journal of the Neurological Sciences.

[18]  A. Boyd,et al.  Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications. , 2008, American heart journal.

[19]  K. Weylandt,et al.  Polyunsaturated fatty acids exert antiarrhythmic actions as free acids rather than in phospholipids , 1996, Lipids.

[20]  P. Amarenco.  Cryptogenic Stroke, Aortic Arch Atheroma, Patent Foramen Ovale, and the Risk of Stroke , 2005, Cerebrovascular Diseases.

[21]  K. Frayn.  Plasma non-esterified fatty acids: why are we not measuring them routinely? , 2005, Annals of clinical biochemistry.

[22]  K. Furie,et al.  An evidence‐based causative classification system for acute ischemic stroke , 2005, Annals of neurology.

[23]  L. Opie.  The metabolic vicious cycle in heart failure , 2004, The Lancet.

[24]  R. DeFronzo,et al.  Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. , 2004, The Journal of clinical endocrinology and metabolism.

[25]  M. Mutanen,et al.  Fats, lipids and blood coagulation , 2001, Current opinion in lipidology.

[26]  L. Opie,et al.  Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias , 1994, The Lancet.

[27]  P. Weber,et al.  Cardiovascular effects of N-3 fatty acids. , 1988, Journal of nutritional science and vitaminology.

[28]  D. Kim,et al.  Regulation of K+ channels in cardiac myocytes by free fatty acids. , 1990, Circulation research.

[29]  Daniel B Hier,et al.  Infarcts of undetermined cause: The NINCDS stroke data bank , 1989, Annals of neurology.

[30]  S. Tasseron,et al.  The effect of a high molar FFA-albumin ratio in the perfusion medium on rhythm and contractility of the isolated rat heart. , 1973, Journal of molecular and cellular cardiology.

[31]  J. C. Hook,et al.  Platelets, Fatty Acids and Thrombosis , 1967, Circulation research.

[32]  W. Connor,et al.  THE ACCELERATION OF THROMBUS FORMATION BY CERTAIN FATTY ACIDS. , 1962, The Journal of clinical investigation.